Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Joshua Levens"'
Autor:
Duoquan Wang, Shan Lv, Wei Ding, Shenning Lu, Hongwei Zhang, Kokouvi Kassegne, Shang Xia, Lei Duan, Xuejiao Ma, Lulu Huang, Roly Gosling, Joshua Levens, Salim Abdulla, Mutinta Mudenda, Moses Okpeku, Kenneth Kamwi Matengu, Potiandi Serge Diagbouga, Ning Xiao, Xiao-Nong Zhou
Publikováno v:
Infectious Diseases of Poverty, Vol 11, Iss 1, Pp 1-6 (2022)
Abstract World Health Organization (WHO) certified China malaria-free on June 30, 2021, which brightens the goal of global malaria elimination efforts. China contributed its unique innovations to the global community: Artemisinin, discovered by Tu Yo
Externí odkaz:
https://doaj.org/article/de75ffb038864110b29c3b4bbfe9274a
Publikováno v:
Infectious Diseases of Poverty, Vol 9, Iss 1, Pp 1-3 (2020)
Externí odkaz:
https://doaj.org/article/c94abcdeafce4dca8da215238c71304c
Autor:
Jessica Couvillion Seidman, Lashaunda Brooke Johnson, Joshua Levens, Harran Mkocha, Beatriz Muñoz, Ellen K Silbergeld, Sheila K West, Christian L Coles
Publikováno v:
Frontiers in Microbiology, Vol 7 (2016)
Enteroaggregative, enteropathogenic, and enterotoxigenic E. coli contribute significantly to the burden of diarrheal infections particularly in developing countries. Antibiotic resistance is increasingly common among bacterial pathogens including pat
Externí odkaz:
https://doaj.org/article/200a956ccd964d39bf96535818e6559b
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 6, Iss 3, p e1576 (2012)
Persistent non-participation of children in mass drug administration (MDAs) for trachoma may reduce program impact. Risk factors that identify families where participation is a problem or program characteristics that foster non-participation are poor
Externí odkaz:
https://doaj.org/article/ffb82921cf4c4e9993f99c038c2d3667
Publikováno v:
Infectious Diseases of Poverty, Vol 9, Iss 1, Pp 1-3 (2020)
Infectious Diseases of Poverty
Infectious Diseases of Poverty
Publikováno v:
Clinical Epidemiology and Global Health. 3:37-43
Background Mass drug administration (MDA) with azithromycin is an important part of trachoma control programs. Maintaining high participation among children is challenging. Aim We assessed factors identifying households with a child who changed parti
Autor:
Beatriz Munoz, Lashaunda B Johnson, Christian L. Coles, Ellen K. Silbergeld, Joshua Levens, Sheila K. West, Jessica C. Seidman, Harran Mkocha
Publikováno v:
International Journal of Epidemiology. 43:1105-1113
Background: Mass drug treatment with azithromycin (MDA) is part of the WHO-endorsed ‘SAFE’ strategy for trachoma control in endemic communities. MDA has been associated with reduced trachoma prevalence and short-term reductions in other bacterial
Autor:
Kasubi Mabula, Harran Mkocha, Joshua Levens, Sheila K. West, Christian L. Coles, Jessica C. Seidman, Beatriz Munoz, Sayoki Mfinanga
Publikováno v:
Clinical Infectious Diseases. 56:1519-1526
BACKGROUND: Emerging evidence suggests that the mass distribution of azithromycin for trachoma control (MDA) may increase circulation of macrolide resistance in bacteria associated with severe pediatric infections in treated communities. METHODS: We
Autor:
Lashaunda Brooke Johnson, Jessica C. Seidman, Harran Mkocha, Beatriz Munoz, Joshua Levens, Sheila K. West, Christian L. Coles, Ellen K. Silbergeld
Publikováno v:
Frontiers in Microbiology, Vol 7 (2016)
Frontiers in Microbiology
Frontiers in Microbiology
Enteroaggregative, enteropathogenic, and enterotoxigenic E. coli contribute significantly to the burden of diarrheal infections particularly in developing countries. Antibiotic resistance is increasingly common among bacterial pathogens including pat
Autor:
Sheila G. West, Beatriz Munoz, Jessica C. Seidman, Christian L. Coles, Joshua Levens, Harran Mkocha
Publikováno v:
Pediatric Infectious Disease Journal. 31:341-346
We evaluated the effect of a single mass distribution of azithromycin for trachoma on the risk of acute lower respiratory infection (ALRI) during a 6-month period among young children living in 8 communities in rural Tanzania.In 8 communities, a coho